Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Alternating and Direct Current Stimulation for Neuropathic Eye Pain

NCT: NCT05931250 · COMPLETED

NCT IDNCT05931250
StatusCOMPLETED
Start Date2023-06-16
Completion2024-12-31
SponsorNeil Lagali (OTHER)
First posted
Last updated

Brief Summary

The goal of this clinical intervention is to test if two forms of transcranial current stimulation, transcranial direct current stimulation (tDCS) or transcranial alternating current stimulation (tACS) can alleviate neuropathic eye pain in a sample of 20 patients. The main aims are: * Test if tDCS/tACS can alleviate neuropathic eye pain and/or other cerebral symptoms: brain fatigue, migraine, light sensitivity, etc. * Test if one stimulation method is superior to the other Patients will be treated for a total of fifteen 30-minute stimulation sessions, three times a day over a five-day period, each stimulation separated by approximately 4 hours, with either active tACS or tDCS over the scalp corresponding to primary sensory and motor areas. The patients will have questionnaires to monitor subjective experiences and pupillometry before and after treatment to monitor experimental outcomes.

Frequently Asked Questions

What is Alternating and Direct Current Stimulation for Neuropathic Eye Pain?

Alternating and Direct Current Stimulation for Neuropathic Eye Pain is a clinical trial registered under NCT05931250. Current status: COMPLETED.

What is the status of NCT05931250?

The current status of NCT05931250 (Alternating and Direct Current Stimulation for Neuropathic Eye Pain) is: COMPLETED.

When did Alternating and Direct Current Stimulation for Neuropathic Eye Pain start?

Alternating and Direct Current Stimulation for Neuropathic Eye Pain started on 2023-06-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.